National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 6) (Cth)

PB 76 of 2021

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 6)

National Health Act 1953

___________________________________________________________________________

I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under paragraph 98C(1) of the National Health Act 1953.

Dated                  27 July 2021

NIKOLAI TSYGANOV

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 6).

(2)This Instrument may also be cited as PB 76 of 2021.

1. Commencement

This Instrument commences on 1 August 2021.

1. Amendments to National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019

Schedule 1 amends the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019.

Schedule 1     Amendments

1. Schedule 4, after entry for Framycetin

insert:

Fremanezumab Solution for injection 225 mg in 1.5 mL single dose pre-filled syringe

1. Schedule 4, entry for Paraffin

insert as first entry:

Paraffin Eye drops containing liquid paraffin, glycerol, tyloxapol, poloxamer-188, trometamol hydrochloride, trometamol, cetalkonium chloride, 10 mL (preservative free)

1. Schedule 4, after entry for Rifampicin

insert:

Risdiplam Powder for oral solution 750 micrograms per mL, 80 mL

1. Schedule 5, omit entry for Dusting Powders

1. Schedule 5, entry for Mixtures, Other

omit:

Mixtures, Other Gentian Alkaline APF

1. Schedule 5, entry for Mixtures, Other

omit:

Mixtures, Other Kaolin and Opium APF 14

1. Schedule 5, omit entry for Mouth Washes